Vaxcyte Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $-29.1M | $36.1M |
| FY2018 | — | $-57.7M | $66.1M |
| FY2019 | — | $-106.4M | $59.0M |
| FY2020 | — | $345.8M | $386.2M |
| FY2021 | — | $284.0M | $69.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $-29.1M | $36.1M |
| FY2018 | — | $-57.7M | $66.1M |
| FY2019 | — | $-106.4M | $59.0M |
| FY2020 | — | $345.8M | $386.2M |
| FY2021 | — | $284.0M | $69.0M |